Skip to content

Author

Özlem Yıldız Gündoğdu

We have 2 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Extended-Release Guanfacine Hydrochloride is Safe and Effective as Mono- and Adjunctive Therapy in Children and Adolescents with ADHD: A Naturalistic, Multi-Center, Patient-Reported Outcome Measures-Based Study.

AIMS Attention-deficit hyperactivity disorder (ADHD) is characterized by impairing and age-inappropriate inattention, hyperactivity, and impulsivity. Extended-release guanfacine hydrochloride (GXR) is a selective α2A-adrenergic agonist approved as mono- and adjunctive therapy to psychostimulant medications for ADHD. Th...

M. Kutuk, A. Tufan, Fethiye Kılıçaslan et al. · 0 citations
Oct 2026

Sociodemographic risk factors and WISC-IV cognitive profile in children with specific learning disorder: a case-control study.

Specific learning disorder (SLD) stems from genetic, environmental, and cognitive factors; however, their relative contributions and the diagnostic validity of cognitive measures remain unclear. This case-control study compared 35 children aged 8-12 diagnosed with SLD according to DSM-5-TR criteria with 35 healthy cont...

Tuba Karakuş Aslan, Ozan Emre Aslan, Özlem Yıldız Gündoğdu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.